Therefore, the difference in RUNX1 and RUNX3 expression level was evaluated between the investigated ALL cohort (n = 60) and 43 adult AML cases, geographically and ethnically matched to the study group. This evidence concerns the gene RUNX3 and acute myeloid leukemia.